Semax Protocol: The Sequence the Research Followed
Three separate documents get called a protocol. The one people find online is the only one with no author, no conditions and nothing behind it.
Search for a Semax protocol and what comes back is a dosing schedule. That is not what the word means in the setting the search implies. In research, a protocol is the full advance specification of an experiment, and a schedule is one line inside it. Three quite different documents get called a protocol in relation to this peptide, they were written by different people for different reasons, and telling them apart is most of the work.
| Document | Written by | What it fixes in advance | Can you read it | What it tells a person |
|---|---|---|---|---|
| Animal study specification | The researchers running it | Species, model, route, timing, controls, blinding, outcome and when it is read | Usually yes, in the methods section | How an experiment was built, in one species |
| Russian instructions for use | A manufacturer, reviewed by a national regulator | Product, indication, population, contraindications, warnings, duration | Rarely, if you do not read Russian | How one authorised product is used, in one country |
| A schedule found online | Unattributed | A number and an interval | Yes, and that is the problem | Almost nothing |
Where the order actually gets placed
Ascension Peptides, Semax
US-based and third-party tested. Enter the code on the payment step and the vial halves before you confirm.
The published certificate for batch 30-05260628 carries a kinetic chromogenic LAL endotoxin test to USP Chapter 85, reporting under 0.20 EU/mL against a 0.5 EU/mL limit, plus a sterility screen. Buying 3, 5 or 10 takes 3%, 5% or 10% off the list price.
- Two batch certificates per lot
- Shipping free over $250
- Out the door same day if you order before 2pm CST
Everything here is research material for laboratory use, not for human consumption. Affiliate links, so we may earn a commission at no cost to you. Prices last checked August 21, 2026.
What a Semax protocol means in each of the three documents
The three overlap in vocabulary and share nothing else. The animal specification is written so another laboratory can repeat the experiment. The Russian document is written so a clinician can use one manufactured product safely for a defined purpose. The online schedule is written so a reader keeps reading and then buys something.
They also differ in what happens if you ignore them. Deviate from the animal specification and the experiment stops being comparable. Deviate from the authorised instructions and a regulator's warnings no longer cover you. Deviate from the online schedule and nothing at all happens, because nothing was underwriting it in the first place.
What an experiment fixes before it starts, and why none of it converts
An animal study specification is long and boring, and the length is the point. It names the species, the strain, the sex, the weight range and the housing. It names the model, meaning the injury or condition induced, and the exact interval between inducing it and giving anything. It states the route, the vehicle, the concentration and the volume. It defines control groups, including the animals that get vehicle only. It states who is blinded to which group. Above all it states the outcome measure and the moment it will be read, before any data exists.
Every one of those fields exists to remove an alternative explanation. The control group removes the possibility that the animals would have improved anyway. Blinding removes the assessor's expectations. Fixing the outcome in advance removes the option of looking at the data and choosing the flattering measurement afterwards.
Now try to move that to a person. Dose in animal work is set per kilogram of body weight in a defined strain under laboratory conditions, which does not scale by arithmetic to a human. The timing is anchored to an insult delivered at a known minute, and a person's problem did not start at a known minute. The route is an experimental control choice rather than a recommendation. And the reading at the end is done by a blinded assessor on an instrument, not by the participant on a Tuesday evening.
What survives the transfer is a shape: give something, wait an interval, expect a change. That shape is the least informative part of the document.
The authorised instructions, and what a copy leaves at the border
The second document is specific to this compound and is the reason it gets discussed differently from most research chemicals. It is real: an authorised product exists in Russia with instructions attached to it, and those instructions passed a national review.
What that document contains is mostly conditions. It applies to one manufactured product with characterised contents. It names indications, and the indication is what the duration was set for. It carries contraindications, interactions and warnings. It assumes a prescriber who examined someone and can stop the course.
What crosses into English is a number and an interval. The product does not cross, because the material on a research chemical site was not made under that authorisation. The indication does not cross, because the reader is usually taking it for something broader. The contraindications almost never cross, because they make poor web copy. The prescriber does not cross at all.
There is a further complication most pages leave out. A reader outside Russia typically cannot read the original document. So the schedule circulating in English is a translation of a summary of a source that nobody in the chain of copying has verified, and errors introduced anywhere along it are invisible by the time they reach a product page.
Tracing a circulating schedule backwards until it runs out
Take any specific schedule you find and follow its citations. The pattern is consistent. An article states it flatly. A second article states it and links the first. A forum post from earlier states something close. A vendor page states it in a product description. Below that there is nothing, and the trail ends in the place it started.
Consistency across pages feels like corroboration and is not. Ten pages copying one unattributed source produce ten instances of one claim.
This compound adds a wrinkle worth spelling out, because it changes what a copied instruction even means. Material is sold both as a lyophilised vial and as a pre-mixed nasal spray. A schedule written as a number of sprays per nostril is an instruction about a container, and containers are not standardised between sellers. Two bottles carrying the same molecule name can hold solutions at different stated concentrations, with pumps that deliver different volumes per actuation, neither figure independently confirmed. The same sentence copied onto both product pages therefore describes two different amounts of material. Anyone treating that sentence as a protocol is treating a packaging detail as pharmacology.
The step the sequence never reaches: how anyone would know
Notice what is missing from every consumer version. There is no defined outcome, no baseline reading, no comparator and no blinded assessor.
In the animal specification the outcome was chosen and timed before the first dose, and read by someone who did not know which group the animal came from. In the authorised setting a clinician assesses against an indication and can stop. In the third version the reader is the participant, the assessor and the person who wants it to have worked, and the reading is an impression formed on an ordinary day that also contained sleep, caffeine, workload and expectation.
That is not a small gap in the schedule. It is the absence of the mechanism that would let a schedule ever be corrected. A protocol without an outcome measure cannot be evaluated, only repeated.